Respiratory Syncytial Virus recombinant glycoprotein F antigen

1 Drug classified under this active ingredient

Respiratory Syncytial Virus (RSV) vaccine. Respiratory Syncytial Virus recombinant glycoprotein F antigen 120 mcg/ 0.5 ml.
Vial, Powder (163 mcg) and suspens. for IM inject. X1/X10
Sgle. dose of 0.5 ml.
Active immunisation for the prevent. of lower respirat. tract dis. (LRTD) caused by respirat. syncytial virus in adults 60 years of age and older.
C/I:Hypersens